InvestorsHub Logo
Followers 145
Posts 27558
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Friday, 08/11/2017 12:42:26 PM

Friday, August 11, 2017 12:42:26 PM

Post# of 2808
ValuEngine upgraded BioLineRx from a sell rating to a hold rating in a research note on Monday, July 17th.

Roth Capital started coverage on BioLineRx in a research note on Thursday, August 3rd. They issued a buy rating and a $3.00 price target for the company.

Finally, Oppenheimer Holdings, Inc. started coverage on BioLineRx in a research note on Friday, August 4th. They issued an outperform rating and a $3.00 price target for the company.

Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. BioLineRx currently has an average rating of Buy and an average price target of $2.59.

https://sportsperspectives.com/2017/08/10/biolinerx-ltd-nasdaqblrx-given-a-4-00-price-target-by-hc-wainwright-analysts.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News